02/11/2026
Day one of a five week clinical trial of Non-invasive neuromodulation with NESA XSIGNAL®
We see it every day in our practice
Patients with persistent pain, fragmented sleep and a sustained state of alertness that limits their progress. We treat the symptom, but the underlying autonomic response remains active.
When the autonomic nervous system remains dysregulated, the body cannot exit vigilance mode and as long as that root cause persists, many treatments will hit a ceiling.
This treatment, NESA XSIGNAL® is a Class IIa medical device designed for a single purpose: non-invasive neuromodulation of the autonomic nervous system.
Through subsensory microcurrents applied at distal low-impedance points, it helps restore the balance between the sympathetic and parasympathetic systems with no sensory perception for the patient and no interference with your clinical protocol.
So here we are the first day of this 5 week trial to integrate it in our Health Recovery Clinic and bring it you! We are so excited!
The outcome observed by professionals who integrate it into their practice is a wider therapeutic window: patients who rest better, tolerate more, and respond sooner.